IDiyas

For the Inventor, By the Inventor

San Clemente, CA, United States of America

Ronnie C Hanecak

USPTO Granted Patents = 14 

Average Co-Inventor Count = 7.3

ph-index = 13

Forward Citations = 614(Granted Patents)


Company Filing History:

goldMedal11 out of 1,035 
 
Isis Pharmaceuticals, Inc.
 patents
silverMedal2 out of 11 
 
Phenex Pharmaceuticals Ag
 patents
bronzeMedal1 out of 1 
 
Phenix Pharmaceuticals Ag
 patent

Years Active: 1996-2006

Loading Chart...
14 patents (USPTO):
1. 7098336 - FXR NR1H4 nuclear receptor binding compounds (2006-08-29),
2. 7067497 - Modulation of telomere length by oligonucleotides having a G-core sequence (2006-06-27),
3. 7034046 - NR1H4 nuclear receptor binding compounds (2006-04-25),
4. 6995146 - Compositions and methods for treatment of hepatitis C virus-associated diseases (2006-02-07),
5. 6974830 - NR1H4 nuclear receptor binding compounds (2005-12-13),
6. 6608191 - Compositions and methods for treatment of hepatitis C virus-associated diseases (2003-08-19),
7. 6423489 - Compositions and methods for treatment of Hepatitis C virus-associated diseases (2002-07-23),
8. 6391542 - Compositions and methods for treatment of Hepatitis C virus-associated diseases (2002-05-21),
9. 6284458 - Compositions and methods for treatment of hepatitis C virus-associated diseases (2001-09-04),
10. 6174868 - Compositions and methods for treatment of hepatitis C virus-associated diseases (2001-01-16),
11. 5952490 - Oligonucleotides having a conserved G4 core sequence (1999-09-14),
12. 5698391 - Methods for synthetic unrandomization of oligomer fragments (1997-12-16),
13. 5672472 - Synthetic unrandomization of oligomer fragments (1997-09-30),
14. 5514577 - Oligonucleotide therapies for modulating the effects of herpes viruses (1996-05-07),

Title: The Innovative Contributions of Ronnie C Hanecak

Introduction

Ronnie C Hanecak is a prominent inventor based in San Clemente, CA. He has made significant contributions to the field of biotechnology, holding a total of 14 patents. His work focuses on developing compounds and methods that have the potential to treat various diseases and conditions.

Latest Patents

One of Hanecak's latest patents involves FXR NR1H4 nuclear receptor binding compounds. This invention provides compounds that bind to the NRH receptor and act as agonists, antagonists, or mixed agonists/antagonists. The invention also outlines methods for treating diseases through the binding of the nuclear receptor by these compounds and the production of medicaments. Another notable patent is related to the modulation of telomere length by oligonucleotides having a G-core sequence. This patent presents modified oligonucleotides with a GGG motif sequence that can modulate the telomere length of chromosomes. It includes methods for inhibiting the division of malignant cells and modulating the effects of cellular aging.

Career Highlights

Throughout his career, Hanecak has worked with several notable companies, including Isis Pharmaceuticals, Inc. and Phenex Pharmaceuticals AG. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Hanecak has collaborated with various professionals in his field, including Kevin P Anderson and Chikateru Nozaki. These collaborations have likely enhanced his research and innovation efforts.

Conclusion

Ronnie C Hanecak's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and understanding of cellular processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…